Literature DB >> 17509470

Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura.

Nicholas S Abend1, Daniel J Licht, Charles H Spencer.   

Abstract

A male adolescent developed a sinovenous thrombosis 4 weeks following a Henoch-Schonlein purpura episode. A hypercoagulation evaluation revealed a positive lupus anticoagulant. This suggests an association between Henoch-Schonlein purpura and antiphospholipid antibody syndrome and is the first report of sinovenous thrombosis after Henoch-Schonlein purpura that was likely due to elevated antiphospholipids. Children who develop Henoch-Schonlein purpura with neurologic features including headache should be evaluated for sinovenous thrombosis and a hypercoagulable state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509470     DOI: 10.1016/j.pediatrneurol.2007.01.005

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

1.  Henoch-Schönlein purpura associated with antiphospholipid syndrome.

Authors:  Hongwen Zhang; Jianping Huang
Journal:  Pediatr Nephrol       Date:  2009-08-25       Impact factor: 3.714

Review 2.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 3.  Thromboembolic disease in vasculitis.

Authors:  Gunnar Tomasson; Paul A Monach; Peter A Merkel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

4.  Thrombosis warning in children suffering from henoch-schonlein purpura.

Authors:  Luan Li; Jingwen Zhang; Yunying Zhang; Hong Ji
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

5.  Life-threatening complications of Henoch-Schönlein purpura: diffuse alveolar haemorrhage, venous thrombosis and bowel ischaemia.

Authors:  Kezreen Kaur Dhaliwal; Nur Atikah Lile; Chou Luan Tan; Chong Hong Lim
Journal:  BMJ Case Rep       Date:  2020-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.